Principal Investigator
David Rosow
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250847
Clinical Trial Summary
A Single-Arm, Open-Label Study of Intralesional Treatment of Laryngeal Squamous Cell Carcinoma with Cisplatin
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Head and Neck Cancer
Contact Information
Phone Number
+1 (305) 2434624